Clinical Trials & Senolytics | Dr. James Kirkland, Mayo Clinic

Seminar summary: https://foresight.org/summary/clinica...
Program & apply to join: https://foresight.org/biotech-health-...

Foresight Biotech & Health Extension Group sponsored by 100 Plus Capital


Dr. James Kirkland, Mayo Clinic: Clinical Trials & Senolytics
James L. Kirkland, M.D., Ph.D., is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland’s research is on the contribution of fundamental aging processes, particularly cellular senescence, to age-related diseases and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities.
Additional research areas include molecular and physiological mechanisms of age-related adipose tissue and metabolic dysfunction, frailty, and loss of resilience to acute diseases in old age. Dr. Kirkland’s laboratory published the first article about agents that clear senescent cells - senolytic drugs. Dr. Kirkland demonstrated that senolytic agents enhance healthspan and delay, prevent, or alleviate multipleage-related disorders and chronic diseases in mouse models. He published the first clinical trials of senolytic drugs and is currently conducting multiple clinical trials of senolytics. He has more than 200 publications and holds over 20 patents. Dr. Kirkland is Principal Investigator of the Translational Geroscience Network (R33 AG061456), which brings together 8 academic institutions to translate healthspan interventions, including senolytics and other drugs that target fundamental aging processes, from bench to bedside. He is a scientific advisory board member for several companies and academic organizations. He is President-Elect of the American Federation for Aging Research, a past member of the National Advisory Council on Aging of the National Institutes of Health, past chair of the Biological Sciences Section of the Gerontological Society of America, and a member of the Clinical Trials Advisory Panel of the National Institute on Aging. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. Dr. Kirkland is the 2020 recipient of the Irving S. Wright Award of Distinction from the American Federation for Aging Research.es. Additional research areas include molecular and physiological mechanisms of age-related adipose tissue and metabolic dysfunction, frailty, and loss of resilience to acute diseases in old age. Dr. Kirkland’s laboratory published the first article about agents that clear senescent cells - senolytic drugs. Dr. Kirkland demonstrated that senolytic agents enhance healthspan and delay, prevent, or alleviate multipleage-related disorders and chronic diseases in mouse models. He published the first clinical trials of senolytic drugs and is currently conducting multiple clinical trials of senolytics. He has more than 200 publications and holds over 20 patents. Dr. Kirkland is Principal Investigator of the Translational Geroscience Network (R33 AG061456), which brings together 8 academic institutions to translate healthspan interventions, including senolytics and other drugs that target fundamental aging processes, from bench to bedside. He is a scientific advisory board member for several companies and academic organizations. He is President-Elect of the American Federation for Aging Research, a past member of the National Advisory Council on Aging of the National Institutes of Health, past chair of the Biological Sciences Section of the Gerontological Society of America, and a member of the Clinical Trials Advisory Panel of the National Institute on Aging. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. Dr. Kirkland is the 2020 recipient of the Irving S. Wright Award of Distinction from the American Federation for Aging Research.

Zoom Transcription:
https://otter.ai/u/6WI4mqc3UB9cRh7etq...

Find a written summary of this talk here (including slides, notes and more):
https://foresight.org/salon/clinical-...

Join us:
► Twitter:   / foresightinst  
► Facebook:   / foresightinst  
► Instagram:   / existentialhope  
► LinkedIn:   / 1801125  
► Support to join: https://foresight.org/donate/membership/

Foresight Institute advances technologies for the long-term future of life, focusing on molecular machine nanotechnology, biotechnology, and computer science.

Follow us here for videos concerning our programs on Molecular Machines, Biotechnology & Health Extension, Intelligent Cooperation, and Existential Hope.